Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


USDA school-approved soda

This article was originally published in The Tan Sheet

Executive Summary

airforce Nutrisoda announces Dec. 14 the U.S. Department of Agriculture approves its line of nutrient-enhanced sodas for inclusion in the U.S. National School Lunch Program. The four flavors USDA approved include Focus, Calm, Slender and Radiant. The drinks include ingredients like ginseng, chamomile, chromium, folic acid, l-tyrosine, inositol and choline, vitamins B2, B3, B5, B6, B12, magnesium and vitamin E. Registered Dietician and Director of Wellness for the manufacturer of airforce Nutrisoda Jennifer Ashley says, "The ingredients in Nutrisodas are specifically designed to achieve tailored wellness goals and provide intelligent refreshment for students." The sodas come in 8.4 fluid ounce cans with "natural colors and fruit flavors, water filtered four times for extra purity and with zero sugar, caffeine, carbohydrates, fat, sodium and zero to very few calories," according to the company...

You may also be interested in...

More Top-Level Pharma Changes In India, Cipla Gets CSO

Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.

India Acts To Limit Supply Disruption From Coronavirus

Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.

Could Revisiting US Approval Decisions Become Less Rare?

While not identifying specific situations raising potential questions, the FDA commissioner uses his appearance at agency's annual rare disease event to advise regulatory decisions may be revisited as more data becomes available. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts